Clinical Trial Update: Inhaled Beclomethasone to Prevent Chronic Lung Disease [Phase 3]

View source ↗

Summary

A Phase 3 NHLBI-sponsored trial of inhaled beclomethasone to prevent chronic lung disease in preterm infants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia
• Neonatal Respiratory Distress Syndrome

Drugs mentioned

• Beclomethasone Dipropionate (beclomethasone dipropionate)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Bronchopulmonary Dysplasia, Hyaline Membrane Disease | Phase 3 | Status: COMPLETED